Markets › India › NSE › SUPRIYA

Supriya Lifescience Ltd

NSE:SUPRIYAHealthcareNSE:NIFTY_MICROCAP250NSE:NIFTY_TOTAL_MKT

₹873.25−1.44%At closeAt close · Mon 19 Oct · ≈ AED 33.74 · Market cap $750.02M · Next earnings Wed 11 Nov

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	60.8%	55.7%	62.1%	49.1%	55.2%	54.2%	—	—
Operating margin	42.7%	38.9%	25.6%	27.6%	34.5%	32.1%	32.1%	+0.0 pts
Net margin	32.1%	29.2%	19.9%	20.9%	27.0%	25.3%	25.3%	+0.0 pts
EBITDA margin	45.9%	42.7%	30.4%	32.2%	38.9%	36.9%	—	—
Return on equity	46.0%	24.7%	12.8%	14.6%	18.9%	17.5%	17.5%	+0.0 pts
Return on assets	27.7%	20.7%	11.0%	12.9%	16.9%	15.4%	15.4%	+0.0 pts
Return on capital employed	54.8%	31.8%	15.9%	18.6%	23.3%	21.5%	—	—
Debt / equity	0.3×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	+0.0%
Debt / assets	16.2%	3.7%	2.7%	0.6%	0.5%	0.4%	—	—
Interest coverage	40.3×	48.2×	37.4×	75.7×	142.6×	140.6×	—	—
Current ratio	1.8×	5.0×	4.9×	5.2×	5.3×	4.4×	4.4×	+0.0%
Quick ratio	1.3×	4.1×	3.6×	4.1×	3.9×	3.1×	—	—
Cash ratio	0.2×	1.7×	0.9×	0.9×	0.9×	0.7×	0.7×	+0.0%
Asset turnover	0.9×	0.7×	0.5×	0.6×	0.6×	0.6×	—	—
Inventory turnover	2.1×	2.5×	1.6×	4.2×	2.6×	2.4×	—	—
Receivables turnover	4.1×	4.3×	4.9×	4.9×	5.1×	3.8×	—	—
Dividend payout	3.2%	2.9%	5.4%	4.1%	3.4%	3.8%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.